Agilent Technologies announces launch of its latest pharmaceutical compliance service
US-based Agilent Technologies has launched the next generation of its Automated Compliance Engine for Agilent Enterprise Edition compliance services.
The updated software enables delivery of more reliable, secure and cost-efficient analytical instrument qualification services to the pharmaceutical industry, said the company.
As a result, Agilent Enterprise Edition is able to get systems in cGMP-compliant labs validated and back into production faster.
The group delivers compliance services that are compatible across techniques for a broad range of analytical instruments and computer systems from multiple vendors.
It provides a selection of equipment qualification plans, tailored equipment qualification reports, and flexible test specifications to accommodate standard operating procedures.
The new compliance engine streamlines electronic review and approval, from the approved qualification plan to a configurable, secure, and digitally signed final report that is audit-ready and consistent across the entire enterprise.
It also enables users to run compliance tests on multiple instruments simultaneously, further reducing downtime.
‘Enterprise Edition ensures that Agilent compliance services are applied uniformly across laboratories, geographies and analytical techniques, independent of manufacturer,’ said Gary Powers, Agilent compliance programme manager.